US equities |
MU $912.50 ▼-0.18% NVDA $217.76 ▼-1.60% SNDK $1,357.17 ▼-3.29% SPCX $147.82 ▼-2.85% AMD $558.50 ▼-2.16% INTC $94.87 ▼-3.31% AAPL $342.31 ▼-0.19% CRWV $68.87 ▲+4.70%
FinancialContent

bioAffinity Technologies, Inc. - Common Stock (NQ:BIAF)

3.870 +0.310 (+8.71%)
Delayed Quote Updated: 3:03 PM EDT, Oct 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about bioAffinity Technologies, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
News headline image
bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies to Ring Nasdaq Closing Bell Today
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
bioAffinity Technologies Appoints Julie Anne Overton Director of Corporate Communications
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
Dow Rises 80 Points; Altamira Therapeutics Shares Plunge ↗
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 80 points on Tuesday. The Dow traded up 0.24% to 33,710.06 while the NASDAQ fell 0.21% to 11,340.24. The S&P 500... 
Via Benzinga
News headline image
Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Dow Edges Higher; Crude Oil Down 1% ↗
U.S. stocks traded mostly flat midway through trading, with the Dow Jones trading slightly higher on Tuesday. The Dow traded up 0.03% to 33,638.42 while the NASDAQ fell 0.07% to 11,356.65. The S&P 500... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Announces Notice to Award U.S. Patent Protecting Novel Compounds for Specific Delivery of Cancer Treatments
From bioAffinity Technologies, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
bioAffinity Technologies Expands Diagnostic Division with Promotions and New Hires to Strengthen Clinical Bench
From bioAffinity Technologies, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
bioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO Meeting
From bioAffinity Technologies, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
bioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business Update
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company’s Scientific and Medical Advisory Board
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies to Report Third Quarter 2022 Financial Results
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Announces Award of Therapeutic Patents in China, Mexico and Australia
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Statera BioPharma (NASDAQ:STAB) shares increased by 33.1% to $0.2 during Friday's pre-market session. The company's market cap stands at $10.4 million. 
Via Benzinga
News headline image
bioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST Conference
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
Why Amylyx Pharmaceuticals Is Trading Higher By Over 8%; Here Are 22 Stocks Moving Premarket ↗
Gainers SAI.TECH Global Corporation (NASDAQ: SAI) rose 42% to $3.21 in pre-market trading after dipping 26% on Thursday. SAI.TECH recently announced the launch of new liquid cooling Bitcoin mining... 
Via Benzinga
News headline image
7 Penny Sleeper Stocks to Buy Before Wall Street Wakes Up ↗
While these market ideas are risky, they offer enough relevance to be intriguing. 
Via InvestorPlace
News headline image
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday ↗
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial... 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >